Triple-negative breast cancer is a particularly aggressive form of the disease with no specific treatment. In a new study led by the University of Pennsylvania’s Rumela Chakrabarti, researchers discovered that, in contrast to many other cancer types, activation of the interferon gamma signaling contributes to disease progression and spread. The findings may help doctors choose a personalized treatment strategy for triple-negative breast cancer patients, depending on their cancer subtype.
- Rates of skin cancer have increased dramatically over recent decades
- Study helps understand why kids of obese mothers may be susceptible to metabolic diseases
- Compelling evidence of neutrino process opens physics possibilities
- Genetically-modified mosquitoes key to stopping Zika virus spread
- Kombucha tea sparks creative materials research solution